Internal Medicine, Nephrology · Austell, GA
NPI
1609938133
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4444 Austell Rd
Austell, GA, 30106
Phone (678) 460-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$252K
3,026 services
Medicare patients, 2024
398
Average age 72
Drug cost, 2024
$1.4M
4,589 prescriptions
Company payments, 2025
$1,521
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna K Schuler was code 99233 (hospital e&m - subsequent), 463 times for 173 patients. In total Anna K Schuler billed 3,026 services in 24 codes, and Medicare paid $252K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 463 | 173 | $93.34 | $43K |
| 99457 E&M - Miscellaneous | Office | 381 | 51 | $38.74 | $15K |
| 99454 E&M - Miscellaneous | Office | 322 | 46 | $37.30 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 286 | 38 | $49.16 | $14K |
| 99458 E&M - Miscellaneous | Office | 278 | 37 | $31.50 | $8,758 |
| 99214 Office E&M - Established | Office | 256 | 124 | $93.32 | $24K |
| 90960 ESRD Related Services (not dialysis) | Office | 256 | 46 | $282.20 | $72K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 251 | 125 | $12.89 | $3,235 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 106 | 22 | $38.65 | $4,096 |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 54 | $61.05 | $5,860 |
| 90966 ESRD Related Services (not dialysis) | Office | 90 | 13 | $229.58 | $21K |
| 99223 Hospital E&M - Initial | Facility | 86 | 78 | $135.90 | $12K |
| 99222 Hospital E&M - Initial | Facility | 36 | 29 | $102.89 | $3,704 |
| 90935 Hemodialysis | Office | 23 | 14 | $57.26 | $1,317 |
| 90962 ESRD Related Services (not dialysis) | Office | 19 | 11 | $162.44 | $3,086 |
By year: 2022 $194K for 1,634 services; 2023 $250K for 2,291 services; 2024 $252K for 3,026 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 116 | 83 | $4.00 | $464 |
| 81002 Clinical Chemistry | 16 | 15 | $3.46 | $55.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna K Schuler prescribed most often to Medicare patients was Amlodipine Besylate, with 278 prescriptions and refills. In total Anna K Schuler wrote 4,589 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 278 | 737 | 86 | $1,367 |
| Hydralazine Hcl Generic | 216 | 581 | 80 | $4,759 |
| Nifedipine Er Nifedipine | 205 | 475 | 66 | $8,645 |
| Atorvastatin Calcium Generic | 193 | 496 | 68 | $1,806 |
| Carvedilol Generic | 160 | 434 | 67 | $1,345 |
| Velphoro Sucroferric Oxyhydroxide | 137 | 157 | 28 | $488K |
| Torsemide Generic | 131 | 331 | 51 | $2,633 |
| Furosemide Generic | 126 | 321 | 49 | $718 |
| Metoprolol Succinate Generic | 111 | 305 | 35 | $1,180 |
| Sevelamer Carbonate Generic | 105 | 206 | 42 | $21K |
| Farxiga Dapagliflozin Propanediol | 100 | 164 | 25 | $93K |
| Famotidine Generic | 90 | 243 | 34 | $827 |
| Losartan Potassium Generic | 90 | 260 | 34 | $928 |
| Allopurinol Generic | 85 | 233 | 28 | $649 |
| Prosol Parenteral Amino Acid 20% No.1 | 78 | 78 | Under 11 | $16K |
Brand drugs: - claims; generic drugs: 3,790 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna K Schuler $1,521 ($1,521 in general payments such as food, travel and fees) from 18 companies. The largest payer was Calliditas Therapeutics US Inc. with $248.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $248 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $235 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $196 |
| Travere Therapeutics, Inc. TVTX | 3 | $189 |
| Akebia Therapeutics Inc AKBA | 2 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $69.25 |
| Amgen Inc. AMGN | 3 | $63.19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $57.91 |
| Ardelyx, Inc. ARDX | 2 | $39.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.